StocksRunner logo
mail
search
 
menu
 
Tango Therapeutics I
$7.80
+2.32%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 

TNGX Stock Analysis & IQ Rating | Tango Therapeutics I

 
 
 

TNGX

 

Tango Therapeutics I

$7.80

 
+$0.27 | +2.32%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 9.7
 
 
MKT CAP
$ 857.82M
 
52W Low
$ 1.03
 
 
VOL
$ 46.78K
 
P/E Ratio
N/A
 
 
AVG VOL
$ 3.57M
 
RSI
48.18
 
 
TREND
Sideways
 
 
 

TNGX Stock IQ

 
lock  Login to see Tango Therapeutics I (TNGX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

TNGX Target Price

 
 
 

Strengths

 

TNGX Rewards

 Trading below its fair value

 
 

Chart

 
 

$8.53   (-8.56%)

$6.05   (+28.93%)

$3.24   (+140.74%)

$3.24   (+140.74%)

 
 
1year
6month
3month
1month
 

TNGX Risk Level

 

TNGX has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 

Risks Indicators

 

 Beta greater than 1.0

 High volatilty

 
 
TNGX Risk Level
LOW
HIGH
 

TNGX Analysts Opinion

 

TNGX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

TNGX Earnings Sentiment

 Below analyst estimate

 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

TNGX Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

TNGX Future Sentiment

 Trading below its fair value

 
 

TNGX Analysts Opinion

TNGX Analysts opinion is negative and it remained unchanged from the past 3 months

 

TNGX Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
67%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
67%
NA
 

TNGX Street Opinion 

TNGX Street view is bullish and have negative views on the near-term outlook

 

TNGX Performance Sentiment

 
Sentiments overview associated with TNGX events and the stock performance.
 
67%
33%
Positive
Negative
8 out of 12
events present
4 out of 12
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$7.56
 
Resistance
Price
 
$6.91
 
 
Current Price Range
 
$9.52
 
 
Show methods +
 
 
 
TNGX Latest Analysis +
 
 
FAQ About TNGX Stock Insights
 

What is TNGX current stock price?

What are TNGX stock strengths?

What risks are associated with TNGX stock?

When is TNGX next earnings report?

What is TNGX market cap and volume?

What is TNGX's current Stock IQ?

Should I buy TNGX stock right now?

Is TNGX a Strong Buy right now?

What does a 'Strong Buy' rating mean for TNGX?

What does a 'Strong Sell' rating mean for TNGX?

What factors influence TNGX's Stock IQ?

 
 
StocksRunner

Explore our TNGX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored TNGX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our TNGX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
StocksRunner Leaders
mail
 
 

TNGX

 

Tango Therapeutics I

 
 

Current Price

 

$7.80

 
+$0.27 | +2.32%
 
 
52W High
$ 9.7
 
 
MKT CAP
$ 857.82M
 
52W Low
$ 1.03
 
 
VOL
$ 46.78K
 
P/E Ratio
N/A
 
 
AVG VOL
$ 3.57M
 
RSI
48.18
 
 
TREND
Sideways
 
 
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

TNGX Rewards

 Trading below its fair value

 
 
 
 
 

TNGX Stock IQ

 
lock  Login to unlock Tango Therapeutics I (TNGX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$8.53   (-8.56%)

$6.05   (+28.93%)

$3.24   (+140.74%)

$3.24   (+140.74%)

 
 
1year
6month
3month
1month
 

TNGX Analysts Opinion

 

TNGX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

TNGX Earnings Sentiment

 Below analyst estimate

 
 

Rating

×
 

Rating

 
 

Momentum

×
 

Momentum

 

TNGX Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

TNGX Future Sentiment

 Trading below its fair value

 
 

TNGX Analysts Opinion

TNGX Analysts opinion is negative and it remained unchanged from the past 3 months

 

TNGX Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
67%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
67%
NA
 

TNGX Street Opinion 

TNGX Street view is bullish and have negative views on the near-term outlook

 

TNGX Risk Level

 

TNGX has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 

Risks Indicators

 

 Beta greater than 1.0

 High volatilty

 
 
TNGX Risk Level
LOW
HIGH
 
TNGX Performance Sentiment
 
Sentiments overview associated with TNGX events and the stock performance.
 
67%
33%
Positive
Negative
8 out of 12
events present
4 out of 12
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$7.56
 
Resistance
Price
 
$6.91
 
 
Current Price Range
 
$9.52
 
 
Show methods +
 
 
 
 
 
 
 

TNGX Latest Analysis

 
 
 

Tango Therapeutics Inc. (TNGX) Discusses Positive Clinical Data and Development Plans for Vopimetostat in MTAP-deleted Cancers - Slideshow.

 

Thu Oct 23, 2025

$7.53 | -13.05%
 
Activity

Tango Therapeutics Inc. (TNGX) Discusses Positive Clinical Data and Development Plans for Vopimetostat in MTAP-deleted Cancers Transcript.

 

Thu Oct 23, 2025

$7.53 | -13.05%
 
Activity

Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial Raises Capital To Fund Advancement. ) revealed data from its ongoing Phase 1/2 study of vopimetostat (TNG462) in patients with .As of September 1 2025 179 patients were enrolled across all histologies with 154 at active .94 tumor evaluable patients were enrolled more than 6 months before the efficacy analysis and included regardless of outcome.Across cancer types overall response rate (ORR) was 27% the disease control rate (

 

Thu Oct 23, 2025

$7.53 | -13.05%
 
Activity

Tango Therapeutics Falls 8% After $225 Mln Financing And Phase 1/2 Data Update . (RTTNews) - Tango Therapeutics Inc. (TNGX) fell 7.97% to $7.97 down $0.69 after announcing the pricing of an underwritten offering and concurrent PIPE expected to raise approximately $225 million.

 

Thu Oct 23, 2025

$7.53 | -13.05%
 
Activity
Momentum

Tango Therapeutics Announces $225 Million Financing. BOSTON Oct. 23 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics Inc. (NASDAQ:) a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines announced today the pricing of an underwritten offering of 21023337 shares of its common stock and pre-funded warrants to purchase up to 3226458 shares of its common stock (the Offering). The offering price of each share of common stock is $8.6

 

Thu Oct 23, 2025

$7.53 | -13.05%
 
Activity
Activity

Tango Therapeutics rises on $225M financing.

 

Thu Oct 23, 2025

$7.53 | -13.05%
 
Momentum

Tango Therapeutics stock rises after strong pancreatic cancer trial data.

 

Thu Oct 23, 2025

$7.53 | -13.05%
 
Momentum
 
 
 
 
 
StocksRunner

Discover TNGX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of TNGX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our TNGX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

TNGX Stock trends

TNGX Stock performance

TNGX Stock analysis

TNGX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

TNGX Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing TNGX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing TNGX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.